Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Joakim Dillner

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Papillomaviridae

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Anatomy

Capsid

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Franceschi Silvia; Cuzick Jack; Herrero Rolando; Dillner Joakim; Wheeler Cosette M
EUROGIN 2008 roadmap on cervical cancer prevention.
Tedeschi Rosamaria; Luostarinen Tapio; Marus Alessia; Bzhalava Davit; Ogmundsdottir Helga M; Dillner Joakim; De Paoli Paolo; Surcel Heljä-Marja; Pukkala Eero; Lehtinen Matti; Lehtinen Tuula
No risk of maternal EBV infection for childhood leukemia.
Hemminki Kari; Dillner Joakim
Editorial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Joakim Dillner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Franceschi Silvia; Cuzick Jack; Herrero Rolando; Dillner Joakim; Wheeler Cosette M
EUROGIN 2008 roadmap on cervical cancer prevention.
International journal of cancer. Journal international du cancer 2009;125(10):2246-55.
2009: Tedeschi Rosamaria; Luostarinen Tapio; Marus Alessia; Bzhalava Davit; Ogmundsdottir Helga M; Dillner Joakim; De Paoli Paolo; Surcel Heljä-Marja; Pukkala Eero; Lehtinen Matti; Lehtinen Tuula
No risk of maternal EBV infection for childhood leukemia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(10):2790-2.
2009: Hemminki Kari; Dillner Joakim
Editorial.
International journal of cancer. Journal international du cancer 2009;125(8):vii.
2009: Silfverdal Lena; Kemetli Levent; Andrae Bengt; Sparén Pär; Ryd Walter; Dillner Joakim; Strander Björn; Törnberg Sven
Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
American journal of obstetrics and gynecology 2009;201(2):188.e1-7.
2009: Holl Katsiaryna; Lundin Eva; Surcel Heljä-Marja; Grankvist Kjell; Koskela Pentti; Dillner Joakim; Hallmans Göran; Wadell Göran; Olafsdottir Gudridur H; Ogmundsdottir Helga M; Pukkala Eero; Lehtinen Matti; Stattin Pär; Lukanova Annekatrin
Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.
International journal of cancer. Journal international du cancer 2009;124(12):2923-8.
2009: Tuomisto Jouko; Holl Katsiaryna; Rantakokko Panu; Koskela Pentti; Hallmans Göran; Wadell Göran; Stattin Pär; Dillner Joakim; Ogmundsdottir Helga M; Vartiainen Terttu; Lehtinen Matti; Pukkala Eero
Maternal smoking during pregnancy and testicular cancer in the sons: a nested case-control study and a meta-analysis.
European journal of cancer (Oxford, England : 1990) 2009;45(9):1640-8.
2009: Vasiljevic Natasa; Andersson Kristin; Bjelkenkrantz Kaj; Kjellström Christer; Månsson Henrik; Nilsson Elise; Landberg Goran; Dillner Joakim; Forslund Ola
The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
International journal of cancer. Journal international du cancer 2009;124(10):2361-6.
2009: Ivarsson Malin I L; Dillner Joakim; Carlson Joyce
Validity of maternal genotypes in DNA from archival pregnancy serum samples.
Clinical chemistry 2009;55(4):842-3.
2009: Arbyn Marc; Martin-Hirsch Pierre; Buntinx Frank; Van Ranst Marc; Paraskevaidis Evangelos; Dillner Joakim
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate.
Journal of cellular and molecular medicine 2009;13(4):648-59.
2009: Bleeker M C G; Heideman D A M; Snijders P J F; Horenblas S; Dillner J; Meijer C J L M
Penile cancer: epidemiology, pathogenesis and prevention.
World journal of urology 2009;27(2):141-50.
2009: Söderlund-Strand Anna; Carlson Joyce; Dillner Joakim
Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus.
Journal of clinical microbiology 2009;47(3):541-6.
2009: Kullander Johanna; Forslund Ola; Dillner Joakim
Staphylococcus aureus and squamous cell carcinoma of the skin.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):472-8.
2009: Kapeu Aline Simen; Luostarinen Tapio; Jellum Egil; Dillner Joakim; Hakama Matti; Koskela Pentti; Lenner Per; Löve Arthur; Mahlamaki Eija; Thoresen Steinar; Tryggvadóttir Laufey; Wadell Göran; Youngman Linda; Lehtinen Matti
Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.
American journal of epidemiology 2009;169(4):480-8.
2009: Meijer Chris J L M; Berkhof Johannes; Castle Philip E; Hesselink Albertus T; Franco Eduardo L; Ronco Guglielmo; Arbyn Marc; Bosch F Xavier; Cuzick Jack; Dillner Joakim; Heideman Daniëlle A M; Snijders Peter J F
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.
International journal of cancer. Journal international du cancer 2009;124(3):516-20.
2009: Naucler Pontus; Ryd Walter; Törnberg Sven; Strand Anders; Wadell Göran; Elfgren Kristina; Rådberg Thomas; Strander Björn; Forslund Ola; Hansson Bengt-Göran; Hagmar Björn; Johansson Bo; Rylander Eva; Dillner Joakim
Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
Journal of the National Cancer Institute 2009;101(2):88-99.
2009: Dickson Nigel P; Ryding Janka; van Roode Thea; Paul Charlotte; Herbison Peter; Dillner Joakim; Skegg David C G
Male circumcision and serologically determined human papillomavirus infection in a birth cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):177-83.
2008: Sturegård Erik; Johnsson Annika; Gustafsson Eva; Dillner Joakim
[Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project]
Läkartidningen 2008;105(50):3648-50.
2008: Reuschenbach Miriam; Waterboer Tim; Wallin Keng-Ling; Einenkel Jens; Dillner Joakim; Hamsikova Eva; Eschenbach Denise; Zimmer Heike; Heilig Bernhard; Kopitz Jürgen; Pawlita Michael; Doeberitz Magnus von Knebel; Wentzensen Nicolas
Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
International journal of cancer. Journal international du cancer 2008;123(11):2626-31.
2008: Johansson Stefan; Buchmayer Susanne; Harlid Sophia; Iliadou Anastasia; Sjöholm Malin; Grillner Lena; Norman Mikael; Sparén Pär; Dillner Joakim; Cnattingius Sven
Infection with Parvovirus B19 and Herpes viruses in early pregnancy and risk of second trimester miscarriage or very preterm birth.
Reproductive toxicology (Elmsford, N.Y.) 2008;26(3-4):298-302.
2008: Vasiljevic Natasa; Nielsen Lone; Doherty Geoff; Dillner Joakim; Forslund Ola; Norrild Bodil
Differences in transcriptional activity of cutaneous human papillomaviruses.
Virus research 2008;137(2):213-9.
2008: Vasiljevic Natasa; Hazard Kristina; Dillner Joakim; Forslund Ola
Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis.
The Journal of general virology 2008;89(Pt 10):2467-74.
2008: Holl Katsiaryna; Surcel Helja-Marja; Koskela Pentti; Dillner Joakim; Hallmans Göran; Wadell Göran; Kaasila Marjo; Olafsdottir Gudridur H; Ogmundsdottir Helga M; Pukkala Eero; Stattino Pär; Lehtinen Matti
Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: a nested case-control study.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2008;116(9):816-22.
2008: Ryding J; French K M; Naucler P; Barnabas R V; Garnett G P; Dillner J
Seroepidemiology as basis for design of a human papillomavirus vaccination program.
Vaccine 2008;26(41):5263-8.
2008: Cuzick Jack; Arbyn Marc; Sankaranarayanan Rengaswamy; Tsu Vivien; Ronco Guglielmo; Mayrand Marie-Helene; Dillner Joakim; Meijer Chris J L M
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Vaccine 2008;26 Suppl 10():K29-41.
2008: Bjerre Pontus; Silfverdal Lena; Dillner Lena; Hagmar Björn; Edvardsson Henrik; Dillner Joakim; Andersson-Ellström Agneta
A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage.
American journal of obstetrics and gynecology 2008;199(1):24.e1-7.
2008: Andrae Bengt; Kemetli Levent; Sparén Pär; Silfverdal Lena; Strander Björn; Ryd Walter; Dillner Joakim; Törnberg Sven
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Journal of the National Cancer Institute 2008;100(9):622-9.
2008: Sjöholm Malin I L; Dillner Joakim; Carlson Joyce
Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry.
Journal of clinical microbiology 2008;46(2):540-5.
2008: Andersson Kristin; Waterboer Tim; Kirnbauer Reinhard; Slupetzky Katharina; Iftner Thomas; de Villiers Ethel-Michele; Forslund Ola; Pawlita Michael; Dillner Joakim
Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(1):189-95.
2008: Söderlund-Strand Anna; Dillner Joakim; Carlson Joyce
High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry.
Clinical chemistry 2008;54(1):86-92.
2008: Kullander Johanna; Handisurya Alessandra; Forslund Ola; Geusau Alexandra; Kirnbauer Reinhard; Dillner Joakim
Cutaneous human papillomavirus 88: remarkable differences in viral load.
International journal of cancer. Journal international du cancer 2008;122(2):477-80.
2008: Bistoletti Peter; Sennfält Karin; Dillner Joakim
Cost-effectiveness of primary cytology and HPV DNA cervical screening.
International journal of cancer. Journal international du cancer 2008;122(2):372-6.
2008: Dillner Joakim; Rebolj Matejka; Birembaut Philippe; Petry Karl-Ulrich; Szarewski Anne; Munk Christian; de Sanjose Silvia; Naucler Pontus; Lloveras Belen; Kjaer Susanne; Cuzick Jack; van Ballegooijen Marjolein; Clavel Christine; Iftner Thomas;
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.
BMJ (Clinical research ed.) 2008;337():a1754.
2008: Dillner Lena; Pagliusi Sonia; Bray Freddie; Lorincz Attila; Kjaer Susanne K; Anttila Ahti; Iversen Ole Eric; Dillner Joakim; Lehtinen Matti; Paavonen Jorma
Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
Acta obstetricia et gynecologica Scandinavica 2008;87(5):489-98.
2007: Lundstig Annika; Dejmek Annika; Eklund Carina; Filinic Ivo; Dillner Joakim
No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
Anticancer research 2007;27(6B):4159-61.
2007: Okroj Marcin; Spiller O Brad; Korodi Zoltan; Tedeschi Rosamaria; Dillner Joakim; Blom Anna M
Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals.
Vaccine 2007;25(48):8102-9.
2007: Naucler Pontus; Ryd Walter; Törnberg Sven; Strand Anders; Wadell Göran; Elfgren Kristina; Rådberg Thomas; Strander Björn; Johansson Bo; Forslund Ola; Hansson Bengt-Göran; Rylander Eva; Dillner Joakim
Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
The New England journal of medicine 2007;357(16):1589-97.
2007: Helgesson Gert; Dillner Joakim; Carlson Joyce; Bartram Claus R; Hansson Mats G
Ethical framework for previously collected biobank samples.
Nature biotechnology 2007;25(9):973-6.
2007: Forslund Ola; Iftner Thomas; Andersson Kristin; Lindelof Bernt; Hradil Eva; Nordin Peter; Stenquist Bo; Kirnbauer Reinhard; Dillner Joakim; de Villiers Ethel-Michele;
Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma.
The Journal of infectious diseases 2007;196(6):876-83.
2007: Leppik Ludmila; Gunst Karin; Lehtinen Matti; Dillner Joakim; Streker Karin; de Villiers Ethel-Michele
In vivo and in vitro intragenomic rearrangement of TT viruses.
Journal of virology 2007;81(17):9346-56.
2007: Koskinen Walter J; Brøndbo Kjell; Mellin Dahlstrand Hanna; Luostarinen Tapio; Hakulinen Timo; Leivo Ilmo; Molijn Anco; Quint Wim G; Røysland Tov; Munck-Wikland Eva; Mäkitie Antti A; Pyykkö Ilmari; Dillner Joakim; Vaheri Antti; Aaltonen Leena-Maija
Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study.
Journal of cancer research and clinical oncology 2007;133(9):673-8.
2007: Lundstig Annika; Stattin Pär; Persson Kenneth; Sasnauskas Kestutis; Viscidi Raphael P; Gislefoss Randi Elin; Dillner Joakim
No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.
International journal of cancer. Journal international du cancer 2007;121(5):1098-102.
2007: Wahlström Cecilia; Iftner Thomas; Dillner Joakim; Dillner Lena;
Population-based study of screening test performance indices of three human papillomavirus DNA tests.
Journal of medical virology 2007;79(8):1169-75.
2007: Sjöholm Malin Ida Linnea; Dillner Joakim; Carlson Joyce
Assessing quality and functionality of DNA from fresh and archival dried blood spots and recommendations for quality control guidelines.
Clinical chemistry 2007;53(8):1401-7.
2007: Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Hansson B G; Rylander E; Dillner J
HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study.
British journal of cancer 2007;97(1):129-32.
2007: Vasiljevic Natasa; Hazard Kristina; Eliasson Linda; Ly Hoang; Hunziker Andreas; de Villiers Ethel-Michele; Norrild Bodil; Dillner Joakim; Forslund Ola
Characterization of two novel cutaneous human papillomaviruses, HPV93 and HPV96.
The Journal of general virology 2007;88(Pt 5):1479-83.
2007: Hazard Kristina; Andersson Kristin; Dillner Joakim; Forslund Ola
Human papillomavirus subtypes are not uncommon.
Virology 2007;362(1):6-9.
2007: Naucler Pontus; Chen Hui-Chi; Persson Kenneth; You San-Lin; Hsieh Chang-Yao; Sun Chien-An; Dillner Joakim; Chen Chien-Jen
Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study.
The Journal of general virology 2007;88(Pt 3):814-22.
2007: Ryding J; Dahlberg L; Wallen-Ohman M; Dillner J
Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.
The Journal of general virology 2007;88(Pt 3):792-802.
2007: Arbyn Marc; Dillner Joakim
Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;38(3):189-97.
2007: Tuohimaa Pentti; Tenkanen Leena; Syvälä Heimo; Lumme Sonja; Hakulinen Timo; Dillner Joakim; Hakama Matti
Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(2):302-7.
2007: French K M; Barnabas R V; Lehtinen M; Kontula O; Pukkala E; Dillner J; Garnett G P
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland.
British journal of cancer 2007;96(3):514-8.
2007: Hazard Kristina; Karlsson Anna; Andersson Kristin; Ekberg Henrik; Dillner Joakim; Forslund Ola
Cutaneous human papillomaviruses persist on healthy skin.
The Journal of investigative dermatology 2007;127(1):116-9.
2007: Tedeschi Rosamaria; Bloigu Aini; Ogmundsdottir Helga M; Marus Alessia; Dillner Joakim; dePaoli Paolo; Gudnadottir Margret; Koskela Pentti; Pukkala Eero; Lehtinen Tuula; Lehtinen Matti
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
American journal of epidemiology 2007;165(2):134-7.
2007: Pukkala Eero; Andersen Aage; Berglund Göran; Gislefoss Randi; Gudnason Vilmundur; Hallmans Göran; Jellum Egil; Jousilahti Pekka; Knekt Paul; Koskela Pentti; Kyyrönen P Pentti; Lenner Per; Luostarinen Tapio; Löve Arthur; Ogmundsdóttir Helga; Stattin Pär; Tenkanen Leena; Tryggvadóttir Laufey; Virtamo Jarmo; Wadell Göran; Widell Anders; Lehtinen Matti; Dillner Joakim
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
Acta oncologica (Stockholm, Sweden) 2007;46(3):286-307.
2006: Dillner Joakim; Andrae Bengt; Westermark Bengt
[Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools]
Läkartidningen 2006;103(44):3377-9.
2006: Zheng Biying; Wiklund Fredrik; Gharizadeh Baback; Sadat Mehdi; Gambelunghe Giovanni; Hallmans Göran; Dillner Joakim; Wallin Keng-Ling; Ghaderi Mehran
Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
Anticancer research 2006;26(5B):3669-74.
2006: Hazard Kristina; Eliasson Linda; Dillner Joakim; Forslund Ola
Subtype HPV38b[FA125] demonstrates heterogeneity of human papillomavirus type 38.
International journal of cancer. Journal international du cancer 2006;119(5):1073-7.
2006: Arbyn Marc; Sasieni Peter; Meijer Chris J L M; Clavel Christine; Koliopoulos George; Dillner Joakim
Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
Vaccine 2006;24 Suppl 3():S3/78-89.
2006: Lehtinen Matti; Herrero Rolando; Mayaud Philippe; Barnabas Ruanne; Dillner Joakim; Paavonen Jorma; Smith Peter G
Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries.
Vaccine 2006;24 Suppl 3():S3/233-41.
2006: Pagliusi Sonia R; Dillner Joakim; Pawlita Michael; Quint Wim G V; Wheeler Cosette M; Ferguson M
Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update.
Vaccine 2006;24 Suppl 3():S3/193-200.
2006: Zheng B Y; Li X D; Wiklund F; Chowdhry S; Angstrom T; Hallmans G; Dillner J; Wallin K L
Detection of adeno-associated virus type 2 genome in cervical carcinoma.
British journal of cancer 2006;94(12):1913-7.
2006: Hansson Mats G; Dillner Joakim; Bartram Claus R; Carlson Joyce A; Helgesson Gert
Should donors be allowed to give broad consent to future biobank research?
The lancet oncology 2006;7(3):266-9.
2006: Tedeschi Rosamaria; Bidoli Ettore; Agren Asa; Hallmans Göran; Wadell Goran; De Paoli Paolo; Dillner Joakim
Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten County, Sweden.
Journal of medical virology 2006;78(3):372-8.
2006: Ferguson Morag; Heath Alan; Johnes Suzanne; Pagliusi Sonia; Dillner Joakim;
Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses.
International journal of cancer. Journal international du cancer 2006;118(6):1508-14.
2006: Davies Philip; Arbyn Marc; Dillner Joakim; Kitchener Henry C; Meijer Chris J L M; Ronco Guglielmo; Hakama Matti
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening.
International journal of cancer. Journal international du cancer 2006;118(4):791-6.
2006: Lundstig Annika; Dillner Joakim
Serological diagnosis of human polyomavirus infection.
Advances in experimental medicine and biology 2006;577():96-101.
2005: Korodi Zoltan; Dillner Joakim; Jellum Egil; Lumme Sonja; Hallmans Göran; Thoresen Steinar; Hakulinen Timo; Stattin Pär; Luostarinen Tapio; Lehtinen Matti; Hakama Matti
Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(12):2952-5.
2005: Dillner Joakim
Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysis.
Clinical chemistry 2005;51(10):1768-9.
2005: Tedeschi R; Luostarinen T; De Paoli P; Gislefoss R E; Tenkanen L; Virtamo J; Koskela P; Hallmans G; Lehtinen M; Dillner J
Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk.
British journal of cancer 2005;93(7):834-7.
2005: Elfgren Kristina; Rylander Eva; Rådberg Thomas; Strander Björn; Strand Anders; Paajanen Kirsti; Sjöberg Inga; Ryd Walter; Silins Ilvars; Dillner Joakim;
Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.
American journal of obstetrics and gynecology 2005;193(3 Pt 1):650-7.
2005: Silins Ilvars; Ryd Walter; Strand Anders; Wadell Göran; Törnberg Sven; Hansson Bengt Göran; Wang Xiaohong; Arnheim Lisen; Dahl Viktor; Bremell Daniel; Persson Kenneth; Dillner Joakim; Rylander Eva
Chlamydia trachomatis infection and persistence of human papillomavirus.
International journal of cancer. Journal international du cancer 2005;116(1):110-5.
2005: Söderlund-Strand Anna; Rymark Per; Andersson Pia; Dillner Joakim; Dillner Lena
Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
Journal of clinical microbiology 2005;43(7):3260-6.
2005: Bistoletti Peter; Ellström Agneta; Dillner Joakim; Sennfält Karin; Sparén Pär; Strander Björn
[Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial]
Läkartidningen 2005;102(24-25):1874-6, 1878-9.
2005: Lundstig Annika; Eliasson Linda; Lehtinen Matti; Sasnauskas Kestutis; Koskela Pentti; Dillner Joakim
Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles.
The Journal of general virology 2005;86(Pt 6):1703-8.
2005: Korodi Zoltan; Wang Xiaohong; Tedeschi Rosamaria; Knekt Paul; Dillner Joakim
No serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: a nested case-control study.
The Journal of infectious diseases 2005;191(12):2008-11.
2005: Anttila Tarja; Tenkanen Leena; Lumme Sonja; Leinonen Maija; Gislefoss Randi Elin; Hallmans Göran; Thoresen Steinar; Hakulinen Timo; Luostarinen Tapio; Stattin Pär; Saikku Pekka; Dillner Joakim; Lehtinen Matti; Hakama Matti
Chlamydial antibodies and risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):385-9.
2005: Sjöholm Malin I L; Hoffmann Gunilla; Lindgren Stefan; Dillner Joakim; Carlson Joyce
Comparison of archival plasma and formalin-fixed paraffin-embedded tissue for genotyping in hepatocellular carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):251-5.
2005: Wang Xiaohong; Sapp Martin; Christensen Neil D; Dillner Joakim
Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology.
The Journal of general virology 2005;86(Pt 1):65-73.
2005: Rommel Oliver; Dillner Joakim; Fligge Claudia; Bergsdorf Christian; Wang Xiaohong; Selinka Hans-Christoph; Sapp Martin
Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA.
Journal of medical virology 2005;75(1):114-21.
2005: Stolt Annika; Kjellin Mimmi; Sasnauskas Kestutis; Luostarinen Tapio; Koskela Pentti; Lehtinen Matti; Dillner Joakim
Maternal human polyomavirus infection and risk of neuroblastoma in the child.
International journal of cancer. Journal international du cancer 2005;113(3):393-6.
2004: Arbyn Marc; Dillner Joakim; Van Ranst Marc; Buntinx Frank; Martin-Hirsch Pierre; Paraskevaidis Evangelos
Re: Have we resolved how to triage equivocal cervical cytology?
Journal of the National Cancer Institute 2004;96(18):1401-2; author reply 1402.
2004: Naucler Pontus; Da Costa Flora Mabota; Ljungberg Otto; Bugalho Antonio; Dillner Joakim
Human papillomavirus genotypes in cervical cancers in Mozambique.
The Journal of general virology 2004;85(Pt 8):2189-90.
2004: Forslund Ola; Lindelöf Bernt; Hradil Eva; Nordin Peter; Stenquist Bo; Kirnbauer Reinhard; Slupetzky Katharina; Dillner Joakim
High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors.
The Journal of investigative dermatology 2004;123(2):388-94.
2004: Silins Ilvars; Wang Xiaohong; Tadesse Amha; Jansen Kathrin U; Schiller John T; Avall-Lundqvist Elisabeth; Frankendal Bo; Dillner Joakim
A population-based study of cervical carcinoma and HPV infection in Latvia.
Gynecologic oncology 2004;93(2):484-92.
2004: Luostarinen T; Lehtinen M; Bjørge T; Abeler V; Hakama M; Hallmans G; Jellum E; Koskela P; Lenner P; Lie A K; Paavonen J; Pukkala E; Saikku P; Sigstad E; Thoresen S; Youngman L D; Dillner J; Hakulinen T
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri.
European journal of cancer (Oxford, England : 1990) 2004;40(7):1058-65.
2004: Dillner Joakim; Brown Darron R
Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?
Expert reviews in molecular medicine 2004;6(9):1-21.
2004: Rollman Erik; Arnheim Lisen; Collier Brian; Oberg Daniel; Hall Håkan; Klingström Jonas; Dillner Joakim; Pastrana Diana V; Buck Chris B; Hinkula Jorma; Wahren Britta; Schwartz Stefan
HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses.
Virology 2004;322(1):182-9.
2004: Arbyn Marc; Buntinx Frank; Van Ranst Marc; Paraskevaidis Evangelos; Martin-Hirsch Pierre; Dillner Joakim
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
Journal of the National Cancer Institute 2004;96(4):280-93.
2004: Stattin Pär; Lumme Sonja; Tenkanen Leena; Alfthan Henrik; Jellum Egil; Hallmans Göran; Thoresen Steinar; Hakulinen Timo; Luostarinen Tapio; Lehtinen Matti; Dillner Joakim; Stenman Ulf-Håkan; Hakama Matti
High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
International journal of cancer. Journal international du cancer 2004;108(3):418-24.
2004: Tuohimaa Pentti; Tenkanen Leena; Ahonen Merja; Lumme Sonja; Jellum Egil; Hallmans Göran; Stattin Pär; Harvei Sverre; Hakulinen Timo; Luostarinen Tapio; Dillner Joakim; Lehtinen Matti; Hakama Matti
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.
International journal of cancer. Journal international du cancer 2004;108(1):104-8.
2003: Szoke Krisztina; Sápy Tamás; Krasznai Zoárd; Hernádi Zoltán; Szládek Györgyi; Veress György; Dillner Joakim; Gergely Lajos; Kónya József
Moderate variation of the oncogenic potential among high-risk human papillomavirus types in gynecologic patients with cervical abnormalities.
Journal of medical virology 2003;71(4):585-92.
2003: Paavonen Jorma; Karunakaran Karuna P; Noguchi Yasuyuki; Anttila Tarja; Bloigu Aini; Dillner Joakim; Hallmans Göran; Hakulinen Timo; Jellum Egil; Koskela Pentti; Lehtinen Matti; Thoresen Steinar; Lam Henry; Shen Caxia; Brunham Robert C
Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer.
American journal of obstetrics and gynecology 2003;189(5):1287-92.
2003: Dillner Joakim
[Testing HPV vaccine is an ethical dilemma. Can we afford not to offer vaccination against an infection which is a cause of cancer?]
Läkartidningen 2003;100(43):3390-1.
2003: Adami Hans-Olov; Kuper Hannah; Andersson Swen-Olof; Bergström Reinhold; Dillner Joakim
Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(9):872-5.
2003: Lehtinen Matti; Koskela Pentti; Ogmundsdottir Helga M; Bloigu Aini; Dillner Joakim; Gudnadottir Margret; Hakulinen Timo; Kjartansdottir Anne; Kvarnung Matias; Pukkala Eero; Tulinius Hrafn; Lehtinen Tuula
Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring.
American journal of epidemiology 2003;158(3):207-13.
2003: Laukkanen Päivi; Koskela Pentti; Pukkala Eero; Dillner Joakim; Läärä Esa; Knekt Paul; Lehtinen Matti
Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.
The Journal of general virology 2003;84(Pt 8):2105-9.
2003: Wang Xiaohong; Wang Zhaohui; Christensen Neil D; Dillner Joakim
Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.
Virology 2003;311(1):213-21.
2003: Stolt Annika; Sasnauskas Kestutis; Koskela Pentti; Lehtinen Matti; Dillner Joakim
Seroepidemiology of the human polyomaviruses.
The Journal of general virology 2003;84(Pt 6):1499-504.
2003: Lehtinen Matti; Pawlita Michael; Zumbach Klaus; Lie Katherine; Hakama Matti; Jellum Egil; Koskela Pentti; Luostarinen Tapio; Paavonen Jorma; Pukkala Eero; Sigstad Eva; Thoresen Steinar; Dillner Joakim
Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.
American journal of obstetrics and gynecology 2003;188(1):49-55.
2002: Tedeschi R; Dillner J; De Paoli P
Laboratory diagnosis of human herpesvirus 8 infection in humans.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(12):831-44.
2002: Grabowska Katarzyna; Wang Xiaohong; Jacobsson Anders; Dillner Joakim
Evaluation of cost-precision rations of different strategies for ELISA measurement of serum antibody levels.
Journal of immunological methods 2002;271(1-2):1-15.
2002: Elfgren Kristina; Jacobs Marcel; Walboomers Jan M M; Meijer Chris J L M; Dillner Joakim
Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia.
Obstetrics and gynecology 2002;100(5 Pt 1):965-71.
2002: Dillner Joakim
[The survey of Danish biobanks suggests a "drop-out" registry]
Läkartidningen 2002;99(44):4384-5.
2002: Lehtinen Matti; Koskela Pentti; Jellum Egil; Bloigu Aini; Anttila Tarja; Hallmans Göran; Luukkaala Tiina; Thoresen Steinar; Youngman Linda; Dillner Joakim; Hakama Matti
Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries.
American journal of epidemiology 2002;156(8):687-92.
2002: Wallin Keng-Ling; Wiklund Fredrik; Luostarinen Tapio; Angström Tord; Anttila Tarja; Bergman Frank; Hallmans Göran; Ikäheimo Irma; Koskela Pentti; Lehtinen Matti; Stendahl Ulf; Paavonen Jorma; Dillner Joakim
A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
International journal of cancer. Journal international du cancer 2002;101(4):371-4.
2002: Ghaderi Mehran; Wallin Keng-Ling; Wiklund Fredrik; Zake Liene Nikitina; Hallmans Göran; Lenner Per; Dillner Joakim; Sanjeevi Carani B
Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes.
International journal of cancer. Journal international du cancer 2002;100(6):698-701.
2002: Sigstad E; Lie A K; Luostarinen T; Dillner J; Jellum E; Lehtinen M; Thoresen S; Abeler V
A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.
British journal of cancer 2002;87(2):175-80.
2002: Bjørge T; Engeland A; Luostarinen T; Mork J; Gislefoss R E; Jellum E; Koskela P; Lehtinen M; Pukkala E; Thoresen S Ø; Dillner J
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.
British journal of cancer 2002;87(1):61-4.
2002: Dillner Joakim
[The new biobank law accepted: a unique chance of improvement]
Läkartidningen 2002;99(24):2774-6.
2002: Silins Ilvars; Avall-Lundqvist Elisabeth; Tadesse Amha; Jansen Kathrin U; Stendahl Ulf; Lenner Per; Zumbach Klaus; Pawlita Michael; Dillner Joakim; Frankendal Bo
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
Gynecologic oncology 2002;85(2):333-8.
2002: Stattin Pär; Adlercreutz Herman; Tenkanen Leena; Jellum Egil; Lumme Sonja; Hallmans Göran; Harvei Sverre; Teppo Lyly; Stumpf Katariina; Luostarinen Tapio; Lehtinen Matti; Dillner Joakim; Hakama Matti
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
International journal of cancer. Journal international du cancer 2002;99(1):124-9.
2002: Silins Ilvars; Tedeschi Rosa Maria; Kallings Ingegerd; Dillner Joakim
Clustering of seropositivities for sexually transmitted infections.
Sexually transmitted diseases 2002;29(4):207-11.
2002: Forslund Ola; Antonsson Annika; Edlund Karin; van den Brule Adrian J C; Hansson Bengt-Göran; Meijer Chris J L M; Ryd Walter; Rylander Eva; Strand Anders; Wadell Göran; Dillner Joakim; Johansson Bo
Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women.
Journal of medical virology 2002;66(4):535-41.
2002: Scott David R; Hagmar Bjorn; Maddox Peter; Hjerpe Anders; Dillner Joakim; Cuzick Jack; Sherman Mark E; Stoler Mark H; Kurman Robert J; Kiviat Nancy B; Manos M Michele; Schiffman Mark
Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.
Cancer 2002;96(1):14-20.
2001: Tedeschi R; Enbom M; Bidoli E; Linde A; De Paoli P; Dillner J
Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.
Journal of clinical microbiology 2001;39(12):4269-73.
2001: Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi C B
Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
Human immunology 2001;62(10):1153-8.
2001: Lehtinen M; Luukkaala T; Wallin K L; Paavonen J; Thoresen S; Dillner J; Hakama M
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;22(1):117-24.
2001: Mork J; Lie A K; Glattre E; Hallmans G; Jellum E; Koskela P; Møller B; Pukkala E; Schiller J T; Youngman L; Lehtinen M; Dillner J
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
The New England journal of medicine 2001;344(15):1125-31.
2001: Lehtinen M; Dillner J; Paavonen J
Vaccinating women against premature death: summary of an International Workshop, Helsinki, Finland, 10.01.2000.
Vaccine 2001;19(11-12):1347-52.
2001: Anttila T; Saikku P; Koskela P; Bloigu A; Dillner J; Ikäheimo I; Jellum E; Lehtinen M; Lenner P; Hakulinen T; Närvänen A; Pukkala E; Thoresen S; Youngman L; Paavonen J
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.
JAMA : the journal of the American Medical Association 2001;285(1):47-51.
2001: Tedeschi R; Kvarnung M; Knekt P; Schulz T F; Szekely L; De Paoli P D; Aromaa A; Teppo L; Dillner J
A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma.
British journal of cancer 2001;84(1):122-5.
2000: Kjellberg L; Wadell G; Bergman F; Isaksson M; Angström T; Dillner J
Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser.
American journal of obstetrics and gynecology 2000;183(5):1238-42.
2000: Dillner J
Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2000;19(1-2):7-23.
2000: Ghaderi M; Nikitina L; Peacock C S; Hjelmström P; Hallmans G; Wiklund F; Lenner P; Blackwell J M; Dillner J; Sanjeevi C B
Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(10):1067-70.
2000: Silins I; Kallings I; Dillner J
Correlates of the spread of human papillomavirus infection.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(9):953-9.
2000: Elfgren K; Kalantari M; Moberger B; Hagmar B; Dillner J
A population-based five-year follow-up study of cervical human papillomavirus infection.
American journal of obstetrics and gynecology 2000;183(3):561-7.
2000: Kibur M; Koskela P; Dillner J; Leinikki P; Saikku P; Lehtinen M; Hakama M
Seropositivity to multiple sexually transmitted infections is not common.
Sexually transmitted diseases 2000;27(8):425-30.
2000: Tedeschi R; Caggiari L; Silins I; Kallings I; Andersson-Ellström A; De Paoli P; Dillner J
Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women.
International journal of cancer. Journal international du cancer 2000;87(2):232-5.
2000: Kjellberg L; Hallmans G; Ahren A M; Johansson R; Bergman F; Wadell G; Angström T; Dillner J
Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection.
British journal of cancer 2000;82(7):1332-8.
2000: Kibur M; af Geijerstamm V; Pukkala E; Koskela P; Luostarinen T; Paavonen J; Schiller J; Wang Z; Dillner J; Lehtinen M
Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination.
Sexually transmitted infections 2000;76(1):13-7.
2000: Wang Z H; Kjellberg L; Abdalla H; Wiklund F; Eklund C; Knekt P; Lehtinen M; Kallings I; Lenner P; Hallmans G; Mählck C G; Wadell G; Schiller J; Dillner J
Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids.
The Journal of infectious diseases 2000;181(2):456-62.
2000: Nelson J H; Hawkins G A; Edlund K; Evander M; Kjellberg L; Wadell G; Dillner J; Gerasimova T; Coker A L; Pirisi L; Petereit D; Lambert P F
A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples.
Journal of clinical microbiology 2000;38(2):688-95.
2000: Wallin K L; van Doornum G J; Andersson-Ellström A; Kallings I; Wiklund F; Hallmans G; Schiller J; Dillner J
Seroepidemiology of human papillomavirus type 73: a sexually transmitted low-risk virus.
International journal of cancer. Journal international du cancer 2000;85(3):353-7.
2000: Koskela P; Anttila T; Bjørge T; Brunsvig A; Dillner J; Hakama M; Hakulinen T; Jellum E; Lehtinen M; Lenner P; Luostarinen T; Pukkala E; Saikku P; Thoresen S; Youngman L; Paavonen J
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
International journal of cancer. Journal international du cancer 2000;85(1):35-9.
1999: Silins I; Wang Z; Avall-Lundqvist E; Frankendal B; Vikmanis U; Sapp M; Schiller J T; Dillner J
Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis.
The Journal of general virology 1999;80 ( Pt 11)():2931-6.
1999: Wallin K L; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
The New England journal of medicine 1999;341(22):1633-8.
1999: Ghaderi M; Hjelmström P; Hallmans G; Wiklund F; Lenner P; Dillner J; Sanjeevi C B
MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia.
Human immunology 1999;60(10):970-3.
1999: Tedeschi R; De Paoli P; Schulz T F; Dillner J
Human serum antibodies to a major defined epitope of human herpesvirus 8 small viral capsid antigen.
The Journal of infectious diseases 1999;179(4):1016-20.
1999: Luostarinen T; af Geijersstam V; Bjørge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller J T; Thoresen S; Youngman L D; Dillner J; Lehtinen M
No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.
International journal of cancer. Journal international du cancer 1999;80(6):818-22.
1999: Kjellberg L; Wang Z; Wiklund F; Edlund K; Angström T; Lenner P; Sjöberg I; Hallmans G; Wallin K L; Sapp M; Schiller J; Wadell G; Mählck C G; Dillner J
Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study.
The Journal of general virology 1999;80 ( Pt 2)():391-8.
1999: Lenner P; Wiklund F; Emdin S O; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
British journal of cancer 1999;79(5-6):927-32.
1999: af Geijersstam V; Eklund C; Wang Z; Sapp M; Schiller J T; Dillner J; Dillner L
A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children.
International journal of cancer. Journal international du cancer 1999;80(4):489-93.
1999: Dillner J; Andersson-Ellström A; Hagmar B; Schiller J
High risk genital papillomavirus infections are not spread vertically.
Reviews in medical virology 1999;9(1):23-9.
1998: Kjellberg L; Wiklund F; Sjöberg I; Wadell G; Angström T; Dillner J; Mählck C G
A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia.
American journal of obstetrics and gynecology 1998;179(6 Pt 1):1497-502.
1998: af Geijersstam V; Kibur M; Wang Z; Koskela P; Pukkala E; Schiller J; Lehtinen M; Dillner J
Stability over time of serum antibody levels to human papillomavirus type 16.
The Journal of infectious diseases 1998;177(6):1710-4.
1998: af Geijersstam V; Wang Z; Lewensohn-Fuchs I; Eklund C; Schiller J T; Forsgren M; Dillner J
Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.
International journal of cancer. Journal international du cancer 1998;76(3):341-4.
1998: Dillner J; Knekt P; Boman J; Lehtinen M; Af Geijersstam V; Sapp M; Schiller J; Maatela J; Aromaa A
Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer.
International journal of cancer. Journal international du cancer 1998;75(4):564-7.
1997: Kónya J; Eklund C; af Geijersstam V; Yuan F; Stuber G; Dillner J
Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein.
The Journal of general virology 1997;78 ( Pt 10)():2615-20.
1997: Bjørge T; Dillner J; Anttila T; Engeland A; Hakulinen T; Jellum E; Lehtinen M; Luostarinen T; Paavonen J; Pukkala E; Sapp M; Schiller J; Youngman L; Thoresen S
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers.
BMJ (Clinical research ed.) 1997;315(7109):646-9.
1997: Bjørge T; Hakulinen T; Engeland A; Jellum E; Koskela P; Lehtinen M; Luostarinen T; Paavonen J; Sapp M; Schiller J; Thoresen S; Wang Z; Youngman L; Dillner J
A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway.
Cancer research 1997;57(18):3989-92.
1997: Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss R E; Hallmans G; Paavonen J; Sapp M; Schiller J T; Hakulinen T; Thoresen S; Hakama M
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
Journal of the National Cancer Institute 1997;89(17):1293-9.
1997: Wang Z; Christensen N; Schiller J T; Dillner J
A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera.
The Journal of general virology 1997;78 ( Pt 9)():2209-15.
1997: Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
Human papillomavirus antibody responses among patients with incident cervical carcinoma.
Journal of medical virology 1997;52(4):436-40.
1997: Strickler H D; Schiffman M H; Eklund C; Glass A G; Scott D R; Sherman M E; Wacholder S; Kurman R J; Manos M M; Schiller J T; Dillner J
Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(3):183-8.
1997: Andersson-Ellström A; Dillner J; Hagmar B; Milsom I
[Sexuality and STD infections among teenage girls. "Unprotected sex" is common in spite of sufficient knowledge about the risks]
Läkartidningen 1997;94(8):619-21.
1996: Wang Z; Hansson B G; Forslund O; Dillner L; Sapp M; Schiller J T; Bjerre B; Dillner J
Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA.
Journal of clinical microbiology 1996;34(12):3056-62.
1996: Sanjeevi C B; Hjelmström P; Hallmans G; Wiklund F; Lenner P; Angström T; Dillner J; Lernmark A
Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women.
International journal of cancer. Journal international du cancer 1996;68(4):409-14.
1996: Chua K L; Wiklund F; Lenner P; Angström T; Hallmans G; Bergman F; Sapp M; Schiller J; Wadell G; Hjerpe A; Dillner J
A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears.
International journal of cancer. Journal international du cancer 1996;68(1):54-9.
1996: Dillner J; Kallings I; Brihmer C; Sikström B; Koskela P; Lehtinen M; Schiller J T; Sapp M; Mårdh P A
Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior.
The Journal of infectious diseases 1996;173(6):1394-8.
1996: Andersson-Ellström A; Dillner J; Hagmar B; Schiller J; Sapp M; Forssman L; Milsom I
Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study.
Sexually transmitted diseases 1996;23(3):234-8.
1996: Tedeschi R; Dillner J; De Paoli P
Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients.
Clinical and diagnostic laboratory immunology 1996;3(3):363-4.
1996: Elfgren K; Bistoletti P; Dillner L; Walboomers J M; Meijer C J; Dillner J
Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.
American journal of obstetrics and gynecology 1996;174(3):937-42.
1996: Lehtinen M; Dillner J; Knekt P; Luostarinen T; Aromaa A; Kirnbauer R; Koskela P; Paavonen J; Peto R; Schiller J T; Hakama M
Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study.
BMJ (Clinical research ed.) 1996;312(7030):537-9.
1995: Heino P; Dillner J; Schwartz S
Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
Virology 1995;214(2):349-59.
1995: Tedeschi R; Foong Y T; Cheng H M; dePaoli P; Lehtinen T; Elfborg T; Dillner J
The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes.
The Journal of general virology 1995;76 ( Pt 6)():1393-400.
1995: Eklund C; Dillner J
A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles.
Journal of virological methods 1995;53(1):11-23.
1995: Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider J W; Kirnbauer R; Dillner J
Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
The Journal of general virology 1995;76 ( Pt 5)():1141-53.
1995: Cheng H M; Foong Y T; AbuSamah A J; Dillner J; Sam C K; Prasad U
Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma.
Cancer immunology, immunotherapy : CII 1995;40(4):251-6.
1995: Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
International immunology 1995;7(4):653-63.
1995: Wikström A; van Doornum G J; Quint W G; Schiller J T; Dillner J
Identification of human papillomavirus seroconversions.
The Journal of general virology 1995;76 ( Pt 3)():529-39.
1995: Lenner P; Dillner J; Wiklund F; Hallmans G; Stendahl U
Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix.
Cancer immunology, immunotherapy : CII 1995;40(3):201-5.
1995: Heino P; Eklund C; Fredriksson-Shanazarian V; Goldman S; Schiller J T; Dillner J
Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma.
Journal of the National Cancer Institute 1995;87(6):437-40.
1995: Dillner J; Wiklund F; Lenner P; Eklund C; Frederiksson-Shanazarian V; Schiller J T; Hibma M; Hallmans G; Stendahl U
Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer.
International journal of cancer. Journal international du cancer 1995;60(3):377-82.
1994: Van Doornum G J; Prins M; Pronk L; Coutinho R A; Dillner J
A prospective study of antibody responses to defined epitopes of human papillomavirus (HPV) type 16 in relationship to genital and anorectal presence of HPV DNA.
Clinical and diagnostic laboratory immunology 1994;1(6):633-9.
1994: Dillner J
Enzyme immunoassay detection of induction of MHC class I expression by synthetic peptides from the E6 and E7 regions of human papillomavirus type 16.
Journal of immunological methods 1994;167(1-2):195-205.
1994: Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
A population-based seroepidemiological study of cervical cancer.
Cancer research 1994;54(1):134-41.
1994: Strickler H D; Dillner J; Schiffman M H; Eklund C; Glass A G; Greer C; Scott D R; Sherman M E; Kurman R J; Manos M
A seroepidemiologic study of HPV infection and incident cervical squamous intraepithelial lesions.
Viral immunology 1994;7(4):169-77.
1993: Lewensohn-Fuchs I; Wester D; Bistoletti P; Elfgren K; Ohlman S; Dillner J; Dalianis T
Serological responses to human papillomavirus type 16 antigens in women before and after renal transplantation.
Journal of medical virology 1993;40(3):188-92.
1993: Cheng H M; Foong Y T; Mathew A; Sam C K; Dillner J; Prasad U
Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay.
Journal of virological methods 1993;42(1):45-51.
1993: Dillner L; Fredriksson A; Persson E; Forslund O; Hansson B G; Dillner J
Antibodies against papillomavirus antigens in cervical secretions from condyloma patients.
Journal of clinical microbiology 1993;31(2):192-7.
1993: Heino P; Goldman S; Lagerstedt U; Dillner J
Molecular and serological studies of human papillomavirus among patients with anal epidermoid carcinoma.
International journal of cancer. Journal international du cancer 1993;53(3):377-81.
1992: Wikström A; Eklund C; Von Krogh G; Lidbrink P; Dillner J
Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata.
Journal of clinical microbiology 1992;30(7):1795-800.
1991: Dillner L; Heino P; Moreno-Lopez J; Dillner J
Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.
Journal of virology 1991;65(12):6862-71.
1991: Cheng H M; Foong Y T; Sam C K; Prasad U; Dillner J
Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors.
Journal of clinical microbiology 1991;29(10):2180-6.
1990: Dillner J
Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames.
International journal of cancer. Journal international du cancer 1990;46(4):703-11.
1990: Foong Y T; Cheng H M; Sam C K; Dillner J; Hinderer W; Prasad U
Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma.
International journal of cancer. Journal international du cancer 1990;45(6):1061-4.
1990: Linde A; Kallin B; Dillner J; Andersson J; Jägdahl L; Lindvall A; Wahren B
Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.
The Journal of infectious diseases 1990;161(5):903-9.
1990: Dillner L; Moreno-Lopez J; Dillner J
Serological responses to papillomavirus group-specific antigens in women with neoplasia of the cervix uteri.
Journal of clinical microbiology 1990;28(3):624-7.
1990: Dillner J; Dillner L; Utter G; Eklund C; Rotola A; Costa S; DiLuca D
Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.
International journal of cancer. Journal international du cancer 1990;45(3):529-35.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Joakim Dillner

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Joakim Dillner (preview)

All Publications